OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing Based Antibiotic Susceptibility Testing in Multi-Center Study

Ads

You May Also Like

ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA

This announcement contains inside information 10 August 2016 14:35 ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA ...

Platelet and Plasma Market to exceed $6.5 billion by 2024: Global Market Insights, Inc.

Platelets and Plasma Market Size By Component, By Application, By Distribution and Regional Outlook ...